- Report
- May 2025
- 196 Pages
Global
From €3142EUR$3,545USD£2,705GBP
€3491EUR$3,939USD£3,006GBP
- Report
- May 2025
- 189 Pages
Global
From €3142EUR$3,545USD£2,705GBP
€3491EUR$3,939USD£3,006GBP
- Report
- February 2025
- 200 Pages
Global
From €3979EUR$4,490USD£3,427GBP
- Report
- July 2025
- 299 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- December 2024
- 171 Pages
Global
From €3500EUR$3,950USD£3,014GBP
- Clinical Trials
- April 2025
- 220 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- August 2024
- 168 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- August 2024
- 49 Pages
Global
From €3540EUR$3,995USD£3,049GBP
- Report
- July 2025
- 175 Pages
Global
From €3979EUR$4,490USD£3,427GBP
- Report
- June 2025
- 150 Pages
Global
From €3323EUR$3,750USD£2,862GBP
- Report
- September 2024
- 343 Pages
Global
From €7045EUR$7,950USD£6,067GBP
- Report
- June 2025
- 150 Pages
Global
From €2392EUR$2,699USD£2,060GBP
- Report
- May 2025
- 200 Pages
Global
From €2207EUR$2,490USD£1,900GBP
- Report
- August 2024
- 200 Pages
Global
From €2207EUR$2,490USD£1,900GBP
- Report
- March 2025
- 175 Pages
Global
From €3979EUR$4,490USD£3,427GBP
- Report
- April 2025
- 150 Pages
Global
From €2880EUR$3,250USD£2,480GBP
€4298EUR$4,850USD£3,701GBP
- Report
- July 2025
- 389 Pages
Global
From €5184EUR$5,850USD£4,465GBP
- Report
- April 2025
- 133 Pages
Global
From €13288EUR$14,995USD£11,444GBP
- Report
- September 2024
- 128 Pages
Global
From €13288EUR$14,995USD£11,444GBP
- Report
- April 2025
- 21 Pages
Global
From €13288EUR$14,995USD£11,444GBP

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that affects millions of people worldwide. It is characterized by difficulty breathing, coughing, and wheezing. COPD is typically treated with a combination of medications, including bronchodilators, inhaled corticosteroids, and antibiotics. The COPD drug market is a subset of the larger respiratory drug market, which includes drugs used to treat asthma, allergies, and other respiratory conditions.
The COPD drug market is highly competitive, with a variety of companies offering different types of medications. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, and Merck. These companies offer a range of COPD medications, including bronchodilators, inhaled corticosteroids, and antibiotics. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of these medications. Show Less Read more